Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000950123-25-000263
Filing Date
2025-01-14
Accepted
2025-01-13 21:44:29
Documents
1
Effectiveness Date
2025-01-14
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9360
  Complete submission text file 0000950123-25-000263.txt   10536
Mailing Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355
Business Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

EIN.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-535076 | Film No.: 25527558
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)